BioWorld MedTech

Oct. 16, 2012

Agreements/contracts: BD Diag, Lab21 in accord to develop cancer detection assays

It only took one successful assay developed by BD Diagnostics (Circle Sparks, Maryland) and Lab21 (Cambridge, UK), for both firms to realize they had something special when it comes to working together to get new products to market. Read More

Washington roundup: Anthem: MP-RAGE MRI a no-go for all indications

Report from Europe: Critical Diagnostics signs four partners for Presage

ICU Medical launches NanoClave connector

Deals roundup: The Gores Group to acquire Therakos from Ortho-Clinical

Grants roundup: Cardinal Health invites providers to apply for patient safety grants

Patent watch: nContact reaches milestone with new coverage of devices

Med-Tech Notes

Product Briefs

People in the News

MDD's Cardio Extra

Today's news in brief

BioWorld

Precision psychiatry beyond, or before, biomarkers

BioWorld

There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...

Keros reports beneficial effects of RKER-065 in ALS model

BioWorld Science

Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.

News in brief

BioWorld Asia

BioWorld Asia briefs for March 17, 2026

First-in-class POLG activator restores mtDNA across mutations

BioWorld Science

Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...